For dofetilide to be available at any institution, three FDA requirements must be fulfilled. First, the institution must complete a staff education process and submit an Education Confirmation Form ...
The Food and Drug Administration (FDA) announced changes to the Tikosyn (dofetilide; Pfizer) Risk Evaluation and Mitigation Strategies (REMS) program. The Food and Drug Administration (FDA) announced ...
Please provide your email address to receive an email when new articles are posted on . Atrial fibrillation is common, affecting approximately 5.2 million patients in 2010 in the United States, and ...
FDA's requirements for the use of dofetilide are described, and one hospital's strategy for meeting the requirements is discussed. Dofetilide is a specific class III antiarrhythmic agent approved for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results